Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

August 6, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

July 13, 2026July 13, 2026

Why Do We Age? The Biology Of Ageing Explained

1
October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

2
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

3
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

4
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

5
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Hovlinc: a new class of ribozyme

Melanoma Chemotherapy Research Associate Job at RGCB

Neuroplasticity: the kinda flexibility shown by the brain

Hovlinc: a new class of ribozyme
  • BiotechToday
  • World

Hovlinc: a new class of ribozyme

bioxone March 30, 2021March 30, 2021

Shagufta Hasan, Amity University

Catalytic RNA, Ribozymes, found in the ribosomes form polypeptide chains by linking amino acids together. The RNA enzyme catalyzes a chemical reaction in a similar way to that of protein enzymes. They also participate in processes like RNA splicing, viral replication etc. Although they have attracted a great deal of research interest, very few have been identified in Homo sapiens. 

Recently, a genome-wide approach to discovering a self-cleaving ribozyme, named Hovlinc, is developed and is now being recognized as a naturally occurring ribozyme in humans. The secondary structure and biochemical properties of this ribozyme indicate that it relates to an unidentified class of compact, self-cleaving ribozymes. The sequence of Hovlinc manifests a clear evolutionary path, from its appearance between ~130 and ~65 million years ago (Ma), to acquiring self-cleavage activity very lately, ~13-10 Ma, in chimpanzees and gorillas, the common predecessors of human. Hovlinc appears to be operative inside an organism and is rooted within a long non-coding RNA belonging to a class of very long intergenic non-coding RNAs. The existence of a catalytic RNA enzyme in lncRNA, which has been defined as being transcripts with lengths exceeding 200 nucleotides that are not translated into protein, creates the possibility that these transcripts could function by carrying catalytic RNA domains, says the researchers as they published. 

Despite having a newly evolved class of ribozyme found, there is yet a lot to be known about this novel enzyme and its entire set of functions.

Also read:COVID herd immunity is probably not possible

Reference: https://www.nature.com/articles/s41589-021-00763-0#MOESM14

  • Why Do We Age? The Biology Of Ageing Explained
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged biochemical reactions enzymes lncRNA mRNA Nature Chemical Biology Ribozymes RNA

One thought on “Hovlinc: a new class of ribozyme”

  1. Pingback: Neuroplasticity: the kinda flexibility shown by the brain - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • Biotechnopedia
  • DNA-Tales

Neuroplasticity: the kinda flexibility shown by the brain

bioxone March 30, 2021

Camelia Bhattacharyya, Amity University Kolkata What is Neuroplasticity? Plasticity is the quality of a material that allows it to easily change its shape or get molded; neuroplasticity is the same when the brain is taken into consideration. Thus, neuroplasticity is the capability of the brain to adapt to certain changes in the lifetime of an […]

Neuroplasticity

Related Post

  • BiotechToday
  • World

Analysis of clinical characteristics of Takayasu’s arteritis patients

BioTech Today July 24, 2021July 23, 2021

Shrestha Dutta, Amity University Kolkata About Takayasu’s arteritis (TA): Takayasu’s arteritis (TA) is a chronic vasculitis of obscure etiology, predominantly influencing the aorta and its essential branches in ladies aged from 20 to 40 years. The assessed occurrence of TA in Europe and the USA is 0.4–2.6 per million individuals, while the pervasiveness is estimated […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Cancer, COVID-19 and reconciling the Riddles

bioxone October 14, 2020October 14, 2020

Srilagna Sarkar, Amity University Kolkata Severe acute respiratory syndrome Coronavirus 2(SARS-CoV-2) and related to the Coronavirus disease as seen has led to a novel degree of disturbance globally. Whether oncology stakeholders, its patients, families or clinicians are adjusting and conforming with the challenges caused by the convergence of the two-life threatening diseases. Two studies by […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • India

Bacterial hydrogen sulphide biogenesis contributes to antibiotic resistance

bioxone June 14, 2021June 16, 2021

 Souradip Mallick, National Institute of Technology, Rourkela Growing antimicrobial resistance is one of the major threats to the world.  It has been estimated that over 10 million deaths each year by 2050 if no action is taken. The World Health Organization (WHO) also apprises that by 2030, drug-resistant diseases could force up to 24 million […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

Why Do We Age? The Biology Of Ageing Explained

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy